This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Facial telangiectasias (spider veins) have been attributed to a variety of etiologies—most commonly chronic UV exposure, hormone therapy or changes, drugs or alcohol, heredity, and as a secondary phenomenon to many diseases. Therapeutic modalities have included electrodesiccation, dermabrasion, argon laser, and, more recently, the flash lamp–pumped pulsed-dye lasers.¹ Initially, it was thought that these instruments had no potential to cause scarring. However, as with any device that delivers photon energy to the skin, untoward consequences, such as textural change, increased or decreased pigmentation, persistent erythema, or various forms of scarring are certainly possible.

The earlier Candela dye laser, the SPTL-1 (Candela Corporation, Weyland, Mass), was employed principally for facial telangiectasias and port-wine stains at fluences of 5 to 7 J/cm², 585 nm, and a 5-mm spot, with resultant purpura as an end point. A subsequent version, the Candela ScleroPlus laser, has 4 wavelengths between 585 and 600 nm, 6 . . . [Full Text of this Article]

Report of Cases


Comment